Sanaz Memarzadeh

Department of Obstetrics and Gynecology, University of California, Los Angeles

Affiliated withUniversity of California, Los Angeles University of California Los Angeles The VA Greater Los Angeles Healthcare System

Research Area

Cancer Research

Biography

Sanaz Memarzadeh has not added Biography.
If you are Sanaz Memarzadeh and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2025

Other Publications

Article	Year
Lymphovascular and perineural invasion in the parametria: a prognostic factor for early-stage cervical cancer. Obstetrics and gynecology\| PubMed ID: 12962952	2003
Non-Peutz-Jeghers syndrome associated ovarian sex cord tumor with annular tubules: a case report. Fertility and sterility\| PubMed ID: 19703688	2009
Cell-autonomous activation of the PI3-kinase pathway initiates endometrial cancer from adult uterine epithelium. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 20855612	2010
Role of autonomous androgen receptor signaling in prostate cancer initiation is dichotomous and depends on the oncogenic signal. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 21518863	2011
Low levels of circulating estrogen sensitize PTEN-null endometrial tumors to PARP inhibition in vivo. Molecular cancer therapeutics\| PubMed ID: 24222661	2013
Tubal Ligation Induces Quiescence in the Epithelia of the Fallopian Tube Fimbria. Reproductive sciences (Thousand Oaks, Calif.)\| PubMed ID: 25736327	2015
A Designed Inhibitor of p53 Aggregation Rescues p53 Tumor Suppression in Ovarian Carcinomas. Cancer cell\| PubMed ID: 26748848	2016
Expression of Stromal Progesterone Receptor and Differential Methylation Patterns in the Endometrium May Correlate with Response to Progesterone Therapy in Endometrial Complex Atypical Hyper... Reproductive sciences (Thousand Oaks, Calif.)\| PubMed ID: 32124398	2020
Retraction Note: An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer. Nature communications\| PubMed ID: 32355227	2020
An asymptomatic anterior vaginal wall endometrioma, a rare manifestation of endometriosis: A case report. Case reports in women's health\| PubMed ID: 32551235	2020
Ga-FAPi-46 diffuse bilateral breast uptake in a patient with cervical cancer after hormonal stimulation. European journal of nuclear medicine and molecular imaging\| PubMed ID: 32651662	2021
Exploring the Potential of Drug Response Assays for Precision Medicine in Ovarian Cancer. International journal of molecular sciences\| PubMed ID: 33396714	2020
Matched sequential tumor molecular profiling in solid malignancies may impact clinical practice. Cancer genetics\| PubMed ID: 33434795	2021
Targeting monoamine oxidase A-regulated tumor-associated macrophage polarization for cancer immunotherapy. Nature communications\| PubMed ID: 34112755	2021
Retraction Note: Birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy. NPJ precision oncology\| PubMed ID: 34376794	2021
Gynecologic tumor board: a radiologist's guide to vulvar and vaginal malignancies. Abdominal radiology (New York)\| PubMed ID: 34435227	2021
A rare case of vulvar extraskeletal myxoid chondrosarcoma: mimics and diagnostic clues. Autopsy & case reports\| PubMed ID: 34458187	2021
Combining ReACp53 with Carboplatin to Target High-Grade Serous Ovarian Cancers. Cancers\| PubMed ID: 34885017	2021
Management of Clitoral Melanoma Presenting as an Exophytic Clitoral Mass: A Case Report and Review of the Literature. Current oncology (Toronto, Ont.)\| PubMed ID: 34898540	2021
cfTrack: A Method of Exome-Wide Mutation Analysis of Cell-free DNA to Simultaneously Monitor the Full Spectrum of Cancer Treatment Outcomes Including MRD, Recurrence, and Evolution. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 35149536	2022
Efficacy of birinapant in combination with carboplatin in targeting platinum‑resistant epithelial ovarian cancers. International journal of oncology\| PubMed ID: 35191515	2022
Inability of ovarian cancers to upregulate their MHC-class I surface expression marks their aggressiveness and increased susceptibility to NK cell-mediated cytotoxicity. Cancer immunology, immunotherapy : CII\| PubMed ID: 35507102	2022
Expression of immune checkpoint regulators, programmed death-ligand 1 (PD-L1/PD-1), cytotoxic T lymphocyte antigen 4 (CTLA-4), and indolaimine-2, 3-deoxygenase (IDO) in uterine mesenchymal t... Diagnostic pathology\| PubMed ID: 36104728	2022
Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant o... Gynecologic oncology\| PubMed ID: 36736157	2023
Pathologic response to neoadjuvant chemotherapy in ovarian cancer and its association with outcome: A surrogate marker of survival. Gynecologic oncology\| PubMed ID: 37716223	2023
Androgen receptor and its correlation with estrogen and progesterone receptors, aimed for identification of cases for future anti-androgen therapy in endometrial cancers. PloS one\| PubMed ID: 37725629	2023
Profiling ovarian cancer tumor and microenvironment during disease progression for cell-based immunotherapy design. iScience\| PubMed ID: 37810241	2023
Percutaneous interstitial brachytherapy ablation for targeting oligometastatic gynecologic cancers. Brachytherapy\| PubMed ID: 38453533	2024
Exploring the Potential of Natural Killer Cell-Based Immunotherapy in Targeting High-Grade Serous Ovarian Carcinomas. Vaccines\| PubMed ID: 38932405	2024
PGC-1α drives small cell neuroendocrine cancer progression toward an ASCL1-expressing subtype with increased mitochondrial capacity. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 39589879	2024